EUCTR2014-001541-24-DE进行中（未招募）1 期
euroenhancement of Interpersonal Psychotherapy in Major Depression
niversity Medical Center Freiburg0 个研究点开始时间: 2015年8月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Major depressive disorder (ICD-10: F32.2 and F33.2)
- •Inpatients at the Department of Psychiatry and Psychotherapy, Freiburg
- •Score of =15 on the 21-item Hamilton Rating Scale for Depression (HAMD)
- •20-60 years of age
- •Ability to provide informed consent
- •Normal or corrected-to-normal vision
- •Absence of any exclusion criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 28
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
- •Major depressive disorder (ICD-10: F32.2 and F33.2)
- •Inpatients at the Department of Psychiatry and Psychotherapy, Freiburg
- •Score of =15 on the 21-item Hamilton Rating Scale for Depression (HAMD)
- •20-60 years of age
- •Ability to provide informed consent
- •Normal or corrected-to-normal vision
- •Absence of any exclusion criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 28
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
- •Major depressive disorder (ICD-10: F32.2 and F33.2)
- •Inpatients at the Department of Psychiatry and Psychotherapy, Freiburg
- •Score of =15 on the 21-item Hamilton Rating Scale for Depression (HAMD)
- •20-60 years of age
- •Ability to provide informed consent
- •Normal or corrected-to-normal vision
- •Absence of any exclusion criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 28
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Hypersensitivity to D-cycloserine
- •Neurological disorders including epilepsy, history of brain injury, encephalitis, or any organic brain syndrome
- •Metallic implants
- •Present pregnancy
- •DSM-V axis I disorder (lifetime) apart from major depression, such as schizophrenia, schizoaffective disorder, any non-bipolar psychotic disorder, bipolar disorders, primary anxiety or obsessive compulsive disorder, mental retardation, signs of impaired cognitive functioning
- •Acute suicidality
- •Psychotic features of MDD
- •Lifetime history for drug/alcohol dependence, or drug/alcohol abuse within the past year
- •Medication with any anxiolytic or antipsychotic drug, except antidepressants for patients
- •Medical conditions including severe cardiac, liver, kidney, endocrine (e.g., diabetes), hematologic disorders (e.g., porphyria or any bleeding abnormalities), other impairing or unstable medical condition or impending surgery
- •Inability to read or understand the study forms and agree to informed consent.
- •Left-handedness
- •Hypersensitivity to D-cycloserine
- •Neurological disorders including epilepsy, history of brain injury, encephalitis, or any organic brain syndrome
- •Metallic implants
- •Present pregnancy
- •DSM-V axis I disorder (lifetime) apart from major depression, such as schizophrenia, schizoaffective disorder, any non-bipolar psychotic disorder, bipolar disorders, primary anxiety or obsessive compulsive disorder, mental retardation, signs of impaired cognitive functioning
- •Acute suicidality
- •Psychotic features of MDD
- •Lifetime history for drug/alcohol dependence, or drug/alcohol abuse within the past year
- •Medication with any anxiolytic or antipsychotic drug, except antidepressants for patients
- •Medical conditions including severe cardiac, liver, kidney, endocrine (e.g., diabetes), hematologic disorders (e.g., porphyria or any bleeding abnormalities), other impairing or unstable medical condition or impending surgery
- •Inability to read or understand the study forms and agree to informed consent.
- •Left-handedness
- •Hypersensitivity to D-cycloserine
- •Neurological disorders including epilepsy, history of brain injury, encephalitis, or any organic brain syndrome
- •Metallic implants
- •Present pregnancy
- •DSM-V axis I disorder (lifetime) apart from major depression, such as schizophrenia, schizoaffective disorder, any non-bipolar psychotic disorder, bipolar disorders, primary anxiety or obsessive compulsive disorder, mental retardation, signs of impaired cognitive functioning
- •Acute suicidality
- •Psychotic features of MDD
- •Lifetime history for drug/alcohol dependence, or drug/alcohol abuse within the past year
- •Medication with any anxiolytic or antipsychotic drug, except antidepressants for patients
- •Medical conditions including severe cardiac, liver, kidney, endocrine (e.g., diabetes), hematologic disorders (e.g., porphyria or any bleeding abnormalities), other impairing or unstable medical condition or impending surgery
- •Inability to read or understand the study forms and agree to informed consent.
- •Left-handedness
研究者
相似试验
招募中
2 期
Augmentation of Interpersonal Psychotherapy (IPT) with D-cycloserineF32.2F33.2Severe depressive episode without psychotic symptomsRecurrent depressive disorder, current episode severe without psychotic symptomsDRKS00007910niversitätsklinikum Freiburg; Sponsordelegation an Prof. Dr. Claus Normann28
已完成
不适用
Effect of Interpersonal Psychotherapy in Depressed WomeMDD.Major depressive disorder, recurrentIRCT20210706051804N1Islamic Azad University30
已完成
不适用
Effectiveness of interpersonal psychotherapy for symptom and cognitive function of depressive disordermajor depressive disorderJPRN-UMIN000001789Department of Psychiatry, Tohoku University Hospital40
招募中
不适用
Effectiveness of Interpersonal Psychotherapy in Patients with Social AnxietyIRCT20161110030822N1Shahid Beheshti University of Medical Sciences20
已完成
不适用
Treating postnatal depression with psychotherapy inclusive of the mother-baby relationship.ACTRN12616000474459The University of Melbourne25